Report Detail
Global Human Respiratory Syncytial Virus Drugs Market Professional Survey Report 2019
- RnM3804061 |
- 04 October, 2019 |
- Global |
- 103 Pages |
- QYResearch |
- Pharma & Healthcare
Human respiratory syncytial virus (HRSV) is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood. A prophylactic medication, palivizumab, can be employed to prevent HRSV in preterm (under 35 weeks gestation) infants, infants with certain congenital heart defects (CHD) or bronchopulmonary dysplasia (BPD), and infants with congenital malformations of the airway. Treatment is limited to supportive care, including oxygen therapy and more advanced breathing support with CPAP or nasal high flow oxygen.
One trend in the market is emergence of new entrants likely to change market dynamics. The growing demand for novel products for the treatment of RSV has fueled the emergence of new entrants that are likely to change the market dynamics during the forecast period.
The active participation of emerging economies toward research and development will drive the growth prospects for the market during the forecast period. The increasing R&D activities in emerging economies for RSV infection and its causes will fuel the development of novel drugs. One of the major factors responsible for the market’s growth is the rising amount of patented therapies for RSV treatment that result in substantial R&D activities from various big pharma companies and research institutes. For instance, in June 2016, the Lancet Respiratory Medicine reported that RSV was the most commonly detected pathogen linked with pneumonia among children in South Africa. Such new findings will increase the scope of anti-RSV drugs in new applications, such as pneumonia.
ROW accounted for the maximum market share during 2017 and continue to dominate the market for the next few years. One of the major factors responsible for the market’s growth in the region is the growing incidence of RSV infections in ROW, including the BRIC nations.
The global Human Respiratory Syncytial Virus Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Human Respiratory Syncytial Virus Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Respiratory Syncytial Virus Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Human Respiratory Syncytial Virus Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Human Respiratory Syncytial Virus Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AstraZeneca
AbbVie
GSK
Teva Pharmaceutical
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Approved Drugs
Off-Label Drugs
Segment by Application
Clinical Diagnostic
Laboratories Physicians' Office
Laboratories Hospitals
Table of Contents
Executive Summary
1 Industry Overview of Human Respiratory Syncytial Virus Drugs
- 1.1 Definition of Human Respiratory Syncytial Virus Drugs
- 1.2 Human Respiratory Syncytial Virus Drugs Segment by Type
- 1.2.1 Global Human Respiratory Syncytial Virus Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Approved Drugs
- 1.2.3 Off-Label Drugs
- 1.3 Human Respiratory Syncytial Virus Drugs Segment by Applications
- 1.3.1 Global Human Respiratory Syncytial Virus Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Clinical Diagnostic
- 1.3.3 Laboratories Physicians' Office
- 1.3.4 Laboratories Hospitals
- 1.4 Global Human Respiratory Syncytial Virus Drugs Overall Market
- 1.4.1 Global Human Respiratory Syncytial Virus Drugs Revenue (2014-2025)
- 1.4.2 Global Human Respiratory Syncytial Virus Drugs Production (2014-2025)
- 1.4.3 North America Human Respiratory Syncytial Virus Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Human Respiratory Syncytial Virus Drugs Status and Prospect (2014-2025)
- 1.4.5 China Human Respiratory Syncytial Virus Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Human Respiratory Syncytial Virus Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Human Respiratory Syncytial Virus Drugs Status and Prospect (2014-2025)
- 1.4.8 India Human Respiratory Syncytial Virus Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Human Respiratory Syncytial Virus Drugs
- 2.3 Manufacturing Process Analysis of Human Respiratory Syncytial Virus Drugs
- 2.4 Industry Chain Structure of Human Respiratory Syncytial Virus Drugs
3 Development and Manufacturing Plants Analysis of Human Respiratory Syncytial Virus Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Human Respiratory Syncytial Virus Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Human Respiratory Syncytial Virus Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Human Respiratory Syncytial Virus Drugs Production and Capacity Analysis
- 4.2 Human Respiratory Syncytial Virus Drugs Revenue Analysis
- 4.3 Human Respiratory Syncytial Virus Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Human Respiratory Syncytial Virus Drugs Regional Market Analysis
- 5.1 Human Respiratory Syncytial Virus Drugs Production by Regions
- 5.1.1 Global Human Respiratory Syncytial Virus Drugs Production by Regions
- 5.1.2 Global Human Respiratory Syncytial Virus Drugs Revenue by Regions
- 5.2 Human Respiratory Syncytial Virus Drugs Consumption by Regions
- 5.3 North America Human Respiratory Syncytial Virus Drugs Market Analysis
- 5.3.1 North America Human Respiratory Syncytial Virus Drugs Production
- 5.3.2 North America Human Respiratory Syncytial Virus Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Human Respiratory Syncytial Virus Drugs Import and Export
- 5.4 Europe Human Respiratory Syncytial Virus Drugs Market Analysis
- 5.4.1 Europe Human Respiratory Syncytial Virus Drugs Production
- 5.4.2 Europe Human Respiratory Syncytial Virus Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Human Respiratory Syncytial Virus Drugs Import and Export
- 5.5 China Human Respiratory Syncytial Virus Drugs Market Analysis
- 5.5.1 China Human Respiratory Syncytial Virus Drugs Production
- 5.5.2 China Human Respiratory Syncytial Virus Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Human Respiratory Syncytial Virus Drugs Import and Export
- 5.6 Japan Human Respiratory Syncytial Virus Drugs Market Analysis
- 5.6.1 Japan Human Respiratory Syncytial Virus Drugs Production
- 5.6.2 Japan Human Respiratory Syncytial Virus Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Human Respiratory Syncytial Virus Drugs Import and Export
- 5.7 Southeast Asia Human Respiratory Syncytial Virus Drugs Market Analysis
- 5.7.1 Southeast Asia Human Respiratory Syncytial Virus Drugs Production
- 5.7.2 Southeast Asia Human Respiratory Syncytial Virus Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Human Respiratory Syncytial Virus Drugs Import and Export
- 5.8 India Human Respiratory Syncytial Virus Drugs Market Analysis
- 5.8.1 India Human Respiratory Syncytial Virus Drugs Production
- 5.8.2 India Human Respiratory Syncytial Virus Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Human Respiratory Syncytial Virus Drugs Import and Export
6 Human Respiratory Syncytial Virus Drugs Segment Market Analysis (by Type)
- 6.1 Global Human Respiratory Syncytial Virus Drugs Production by Type
- 6.2 Global Human Respiratory Syncytial Virus Drugs Revenue by Type
- 6.3 Human Respiratory Syncytial Virus Drugs Price by Type
7 Human Respiratory Syncytial Virus Drugs Segment Market Analysis (by Application)
- 7.1 Global Human Respiratory Syncytial Virus Drugs Consumption by Application
- 7.2 Global Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application (2014-2019)
8 Human Respiratory Syncytial Virus Drugs Major Manufacturers Analysis
- 8.1 AstraZeneca
- 8.1.1 AstraZeneca Human Respiratory Syncytial Virus Drugs Production Sites and Area Served
- 8.1.2 AstraZeneca Product Introduction, Application and Specification
- 8.1.3 AstraZeneca Human Respiratory Syncytial Virus Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 AbbVie
- 8.2.1 AbbVie Human Respiratory Syncytial Virus Drugs Production Sites and Area Served
- 8.2.2 AbbVie Product Introduction, Application and Specification
- 8.2.3 AbbVie Human Respiratory Syncytial Virus Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 GSK
- 8.3.1 GSK Human Respiratory Syncytial Virus Drugs Production Sites and Area Served
- 8.3.2 GSK Product Introduction, Application and Specification
- 8.3.3 GSK Human Respiratory Syncytial Virus Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Teva Pharmaceutical
- 8.4.1 Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Production Sites and Area Served
- 8.4.2 Teva Pharmaceutical Product Introduction, Application and Specification
- 8.4.3 Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
9 Development Trend of Analysis of Human Respiratory Syncytial Virus Drugs Market
- 9.1 Global Human Respiratory Syncytial Virus Drugs Market Trend Analysis
- 9.1.1 Global Human Respiratory Syncytial Virus Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Human Respiratory Syncytial Virus Drugs Regional Market Trend
- 9.2.1 North America Human Respiratory Syncytial Virus Drugs Forecast 2019-2025
- 9.2.2 Europe Human Respiratory Syncytial Virus Drugs Forecast 2019-2025
- 9.2.3 China Human Respiratory Syncytial Virus Drugs Forecast 2019-2025
- 9.2.4 Japan Human Respiratory Syncytial Virus Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Human Respiratory Syncytial Virus Drugs Forecast 2019-2025
- 9.2.6 India Human Respiratory Syncytial Virus Drugs Forecast 2019-2025
- 9.3 Human Respiratory Syncytial Virus Drugs Market Trend (Product Type)
- 9.4 Human Respiratory Syncytial Virus Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Human Respiratory Syncytial Virus Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Human Respiratory Syncytial Virus Drugs. Industry analysis & Market Report on Human Respiratory Syncytial Virus Drugs is a syndicated market report, published as Global Human Respiratory Syncytial Virus Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Human Respiratory Syncytial Virus Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
